BACKGROUND/AIM: Quality of life (QoL) in early breast cancer (BC) treatment may be affected by acute and late toxicities. This study evaluated the impact of radiotherapy (RT) schedules, treatment-related toxicities, hormone therapy (HT) and age on QoL. PATIENTS AND METHODS: Ninety-five patients answered the FACT-B 4.0 questionnaire. Acute or late toxicities were recorded at each follow-up visit. RESULTS: The median trend of the QoL subscales was stable during all questionnaires. HT negatively impacted on Functional Assessment of Cancer Therapy-General-Total, functional and emotional wellbeing. No difference was recorded between RT schedules and toxicity. No significant differences for age were detected in QoL. CONCLUSION: RT seems not to influence QoL of BC patients, in terms of fractionation regimen or RT-related side-effects. Moreover, women having systemic HT experienced a QoL worse than patients treated with RT only. Further and long-term protocols are needed to improve the validity of the tool. Copyright
BACKGROUND/AIM: Quality of life (QoL) in early breast cancer (BC) treatment may be affected by acute and late toxicities. This study evaluated the impact of radiotherapy (RT) schedules, treatment-related toxicities, hormone therapy (HT) and age on QoL. PATIENTS AND METHODS: Ninety-five patients answered the FACT-B 4.0 questionnaire. Acute or late toxicities were recorded at each follow-up visit. RESULTS: The median trend of the QoL subscales was stable during all questionnaires. HT negatively impacted on Functional Assessment of Cancer Therapy-General-Total, functional and emotional wellbeing. No difference was recorded between RT schedules and toxicity. No significant differences for age were detected in QoL. CONCLUSION: RT seems not to influence QoL of BC patients, in terms of fractionation regimen or RT-related side-effects. Moreover, women having systemic HT experienced a QoL worse than patients treated with RT only. Further and long-term protocols are needed to improve the validity of the tool. Copyright
Authors: Annamaria Porreca; Salvador Cruz Rambaud; Francesca Scozzari; Marta Di Nicola Journal: Int J Public Health Date: 2019-05-27 Impact factor: 3.380
Authors: Julie B Schnur; Suzanne C Ouellette; Terry A Dilorenzo; Sheryl Green; Guy H Montgomery Journal: Psychooncology Date: 2011-03 Impact factor: 3.894
Authors: O Di Bella; R A Cocchiara; A De Luca; F Frusone; V Aceti; C Sestili; V D'Egidio; A Mannocci; M Monti; G La Torre Journal: Clin Ter Date: 2018 Jul-Aug
Authors: Julie Arsenault; Sameer Parpia; Mira Goldberg; Eileen Rakovitch; Harold Reiter; Mary Doherty; Himu Lukka; Jonathan Sussman; James Wright; Jim Julian; Timothy Whelan Journal: Int J Radiat Oncol Biol Phys Date: 2020-04-22 Impact factor: 7.038
Authors: Nadia A Nabulsi; Khatija W Naing; Huiwen Deng; Jenilee Cueto; Alemseged A Asfaw; Colin C Hubbard; Jifang Zhou; Inyoung Lee; Debanjali Mitra; Gregory S Calip; Ernest H Law Journal: J Patient Exp Date: 2022-07-11
Authors: Isamme AlFayyad; Mohamad Al-Tannir; Jude Howaidi; Dana AlTannir; Amani Abu-Shaheen Journal: Qual Life Res Date: 2022-04-30 Impact factor: 3.440